A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Afoxolaner | CAS 1093861-60-9 - Request Quote

Picture of Afoxolaner
SZ CAT No:SZ-A199001
CAS No
1093861-60-9
Mol.F.
C26H17ClF9N3O3
Mol.Wt.
625.9
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Afoxolaner is chemically 4-(5-(3-Chloro-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)-1-naphthamide. Afoxolaner is supplied with detailed characterization data compliant with regulatory guideline. Afoxolaner can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Afoxolaner.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1093861-60-9

Purchase 1093861-60-9

Order 1093861-60-9

Enquire 1093861-60-9

price of 1093861-60-9

1093861-60-9 Supplier

1093861-60-9 Manufacturer

1093861-60-9 Exporter

buy high quality Afoxolaner

Purchase Afoxolaner

Afoxolaner suppliers

Afoxolaner manufacturers

Afoxolaner price

Order Afoxolaner

Enquire Afoxolaner

Afoxolaner cost

Afoxolaner Supplier

Afoxolaner Distributor

Afoxolaner for Method Validation

Afoxolaner Reference Standard

Afoxolaner for ANDA Filing

Afoxolaner for Forced Degradation Studies

Afoxolaner Identification Standards

Afoxolaner for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,